Embracing artificial intelligence design for better radiopharmaceuticalsOA
Embracing artificial intelligence design for better radiopharmaceuticals
Jinping Tao;Xiangxing Kong;Zhi Yang;Hua Zhu
Department of Nuclear Medicine,Peking University Cancer Hospital&Institute,Key Laboratory of Carcinogenesis and Translational Research,Ministry of Education/Beijing,Key Laboratory for Research and Evaluation of Radiopharmaceuticals,National Medical Products Administration,Beijing,China||School of Medicine,Guizhou University,Guiyang,ChinaDepartment of Nuclear Medicine,Peking University Cancer Hospital&Institute,Key Laboratory of Carcinogenesis and Translational Research,Ministry of Education/Beijing,Key Laboratory for Research and Evaluation of Radiopharmaceuticals,National Medical Products Administration,Beijing,China||Institute of Medical Technology,Peking University Health Science Center,Beijing,ChinaDepartment of Nuclear Medicine,Peking University Cancer Hospital&Institute,Key Laboratory of Carcinogenesis and Translational Research,Ministry of Education/Beijing,Key Laboratory for Research and Evaluation of Radiopharmaceuticals,National Medical Products Administration,Beijing,China||School of Medicine,Guizhou University,Guiyang,ChinaDepartment of Nuclear Medicine,Peking University Cancer Hospital&Institute,Key Laboratory of Carcinogenesis and Translational Research,Ministry of Education/Beijing,Key Laboratory for Research and Evaluation of Radiopharmaceuticals,National Medical Products Administration,Beijing,China||School of Medicine,Guizhou University,Guiyang,China||Institute of Medical Technology,Peking University Health Science Center,Beijing,China||Department of Chemistry,Beijing University of Technology,Beijing,China
artificial intelligenceradiopharmaceuticalsnuclear medicine
artificial intelligenceradiopharmaceuticalsnuclear medicine
《智能影像学(英文)》 2024 (4)
412-416,5
Capital's Funds for Health Improvement and Research,Grant/Award Numbers:2022-2Z-2154,2022-2Z-2155Youth talent support program,Grant/Award Number:A002863
评论